Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Mar;59(3):421–425. doi: 10.1038/bjc.1989.85

Predictors of hormone response for patients with ER-unknown breast tumours.

V Hug 1, H Thames 1, S Bentzen 1
PMCID: PMC2247060  PMID: 2930708

Abstract

Characteristics of cells that are associated with the hormonal dependence of tumours are described, and it is shown that clonogenicity and hormone-induced proliferative response of breast tumours are as good markers of hormonal dependence as is oestrogen receptor. Thus tumours that formed less than 150 colonies per 500,000 cells seeded and that increased their proliferative activity 1.8-fold or more in response to hormones were the tumours that were likely to respond to endocrine treatments, whereas all other tumours were likely to be refractory to endocrine treatments. These two criteria (clonogenicity and proliferative response to growth hormones) correctly identified the response to subsequent endocrine treatments in 15 out of 17 patients with oestrogen receptor-unknown tumours. It is proposed that they may constitute a substitute for the oestrogen receptor status in patients with non-biopsiable tumours, and an additional discriminant where the oestrogen receptor assay is available.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gross G. E., Boldt D. H., Osborne C. K. Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res. 1984 Aug;44(8):3570–3575. [PubMed] [Google Scholar]
  2. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  3. Holley R. W. Control of growth of mammalian cells in cell culture. Nature. 1975 Dec 11;258(5535):487–490. doi: 10.1038/258487a0. [DOI] [PubMed] [Google Scholar]
  4. Hug V., Haynes M., Rashid R., Spitzer G., Blumenschen G., Hortobagyi G. Improved culture conditions for clonogenic growth of primary human breast tumours. Br J Cancer. 1984 Aug;50(2):207–213. doi: 10.1038/bjc.1984.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lippman M. E., Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature. 1975 Aug 14;256(5518):592–593. doi: 10.1038/256592a0. [DOI] [PubMed] [Google Scholar]
  6. Wang G., Vogel C. L., Hilsenbeck S. G., Voigt W., Thomsen S. Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer. Breast Cancer Res Treat. 1984;4(4):283–288. doi: 10.1007/BF01806040. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES